Can you please help me with this short but detailed reportexplaining, describing, and analyzing the data collected.Can you talk about oxycodone and pharmaceutical industry.

(The survey that was provided)

Your Demographic Information: Gender: Woman Man Other Ethnic Identity (fill in): Age: Social Class (circle one): Lower Working Middle Upper Instructions: This survey is intended to gather information concerning the use of psychoactive substances (i.e., drugs). Psychoactive substances affect the brain/mind and body and include different classifications, such as stimulants, depressants, sedative-hypnotics, and hallucinogens. Please read each statement below and either fill in the blank line or circle the proper response. The scale runs from 1 to 5. Below are what the numbers mean: Strongly Disagree=1 Disagree=2 Neutral=3 Agree=4 Strongly Agree=5 Substances have been a problem in my life: 1 2 3 4 5 Substance use has altered my perceptions (the way I think): 1 2 3 4 5 Substance use/abuse is major national problem: 1 2 3 4 S Pharmaceutical companies have contributed to the drug epidemic: 1 2 3 4 5 'What was your age when you first tried any substance? Which substance was it? Did you first use this substance alone or with others (ex: friends)? ~ Alone With Others Have you ever had a substance use problem? Yes No Have you ever received any kind of professional treatment for substances? Yes No Circle each substance that you have used at any time during your life: alcohol caffeine tobaccoicotine marijuana amphetamines cocaine heroin oxycodone hydrocodone LSD psilocybin mushrooms opioids ecstasy/ MDMA inhalants GHB sedative/hypnotics over-the-counter meds Specific/Other drugs: Symmetric Measures Approximate Value Significance Nominal by Nominal Phi 330 .007 Cramer's V .330 .007 N of Valid Cases 128 Bar Chart Pharmaindustry 50 USWNH 40 30 Count 20 10 Yes No OxycodoneCrosstabs Case Processing Summary Cases Valid Missing Total N Percent N Percent N Percent Oxycodone * 128 98.5% 2 1.5% 130 100.0% Pharmalndustry Oxycodone * Pharmaindustry Crosstabulation Double-click to Pharmalndustry activate 1 2 3 4 5 Total Oxycodone Yes Count 0 0 3 1 19 23 % within Oxycodone 0.0% 0.0% 13.0% 4.3% 82.6% 100.0% No Count 6 24 31 43 105 % within Oxycodone 1.0% 5.7% 22.9% 29.5% 41.0% 100.0% Total Count 6 27 32 62 128 % within Oxycodone 0.8% 4.7% 21.1% 25.0% 48.4% 100.0% Chi-Square Tests Asymptotic Significance Value df (2-sided) Pearson Chi-Square 13.937 4 007 Likelihood Ratio 16.406 4 003 Linear-by-Linear 8.715 1 003 Association N of Valid Cases 128 a. 5 cells (50.0%) have expected count less than 5. The minimum expected count is . 18